Sartorius AG (SARTF)
Sartorius AG operates in the Medical - Instruments & Supplies industry of the Healthcare sector, headquartered in Goettingen, NI, DE. The stock last traded at $212.80, up 0.00% on the session, giving a market capitalisation of $14.69B. On trailing twelve-month figures it carries a trailing P/E of 83.39, a net margin of 4.8%. Its beta of 1.47 implies it has historically moved more than the broad market.
Sartorius AG engages in the provision of solutions for biopharmaceutical research. It operates through following divisions: Bioprocess Solutions (BPS), and Lab Products and Service (LPS). The Bioprocess Solutions division focuses on single-use solutions, helps customers manufacture biotech medications and vaccines safely and efficiently. The Lab Products and services division serves the needs of laboratories performing research and quality control at pharma and biopharma companies and those of academic research institutes. The company was founded by Florence Sartorius, Sr. in 1870 and is headquartered in Goettingen, Germany.
Sartorius AG is most often compared with the following Healthcare names: